No Data
No Data
Daan Gene Gets Approval for Whopping Cough Detection Kit
Daan Gene Co.,Ltd. (002030.SZ): Pertussis nucleic acid detection kit obtains medical instrument registration certificate.
On September 10, Gelunhui reported that daan gene co.,ltd. (002030.SZ) recently obtained a medical equipment registration certificate issued by the National Medical Products Administration, specifically for: the medical equipment is the Pertussis nucleic acid detection kit (PCR-fluorescent probe method), registration certificate number: NMPA Approval No. 20243401714. The validity period is from the date of approval to September 9, 2029. This test kit is used for in vitro qualitative detection of pertussis nucleic acid in human nasopharyngeal swab samples.
Daan Gene: 2024 Semi-Annual Report
Daan Gene: 2024 Semi-Annual Report Summary
daan gene co.,ltd. (002030.SZ): a net loss of 0.399 billion yuan in the first half of the year.
daan gene co.,ltd. (002030.SZ) announced its semi-annual report for the year 2024 on August 30th. During the reporting period, the company achieved revenue of 0.4 billion yuan, a year-on-year decrease of 25.33%. The net income attributable to shareholders of the listed company was -0.399 billion yuan, with a year-on-year change from profit to loss. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was -0.179 billion yuan. The basic earnings per share was -0.28 yuan.
Express News | Daan Gene Says It Swings to Net Loss 399.2 Mln Yuan in H1
No Data
No Data